InsidersTradesSigma
Track the 녹십자 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 녹십자 has published 2 insider filings. Market capitalisation: €1,280.6bn. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: 정재욱. Every trade is openly available.
Analysts rate 녹십자 Buy (bullish), based on 8 analysts. Average price target: ₩198,500.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
녹십자是一家韩国公司，专注于健康和制药领域。它在XKRX市场上市。